Product Description
Discover an astoundingly effective deal with Tenofovir (300 mg) - Emtricitabine (200 mg) - Efavirenz (600 mg) Tablets, the preeminent choice for first-line antiretroviral therapy. This reduced offer provides 30 enviable, film-coated, capsule-shaped, white or off-white tablets per durable HDPE bottle. Designed for oral administration, its international brand equivalent, Atripla, enjoys WHO prequalification as well as FDA and EMA approved alternatives. Specifically indicated for the treatment of HIV-1 infection in adults and adolescents, this combination's mode of action swiftly suppresses viral replication, offering remarkable therapeutic benefit. Prescription only-seize this opportunity today!
Key Features and Specific Usage
Tenofovir (300 mg) - Emtricitabine (200 mg) - Efavirenz (600 mg) Tablets offer the enviable advantage of a once-daily oral regimen, helping patients maintain high adherence. The film-coated formula combines NRTI and NNRTI actions for robust HIV-1 viral suppression. With a 36-month shelf life and easy storage below 30C, this capsule-shaped tablet is suitable for adults and adolescents above 12 years. Only to be used under prescription, it supports reliable and sustained antiretroviral treatment.
International Export Markets and Logistics
Our preeminent export service reaches global markets, including Asia, Africa, and Latin America. Exporters, suppliers, and traders in India benefit from a quick dispatch and secure shipping process, ensuring product integrity on arrival. Payment terms usually include advance payment or negotiable credit, with quotations provided upon request. Delivery time varies by destination, but efficient logistic partners ensure timely arrival, making the transaction seamless and dependable for bulk buyers.
FAQ's of Tenofovir (300 mg) - Emtricitabine (200 mg) - Efavirenz (600 mg) Tablets:
Q: How should Tenofovir - Emtricitabine - Efavirenz tablets be taken for maximum benefit?
A: Take one film-coated tablet orally once daily, with or without food, at a fixed time every day to maintain optimal blood levels and maximize HIV-1 viral suppression.
Q: What are the main benefits of choosing this antiretroviral combination therapy?
A: This combination provides an enviable level of effectiveness against HIV-1 by utilizing both NRTI and NNRTI mechanisms, offering robust viral suppression and simplified daily dosing for improved adherence.
Q: When should someone avoid using these tablets?
A: The product should not be used by people with hypersensitivity to any component, children under 12 years, pregnant women (unless prescribed), or in combination with contraindicated medicines such as St. John's Wort.
Q: Where is Tenofovir - Emtricitabine - Efavirenz manufactured and registered?
A: These tablets are registered and manufactured in India, exported to various international markets, and comparable to the global brand Atripla.
Q: What is the process for ordering bulk quantities internationally?
A: To order, request a quotation from an authorized exporter or supplier in India. Upon agreement of competitive terms and quick dispatch, expect secure packaging, reliable delivery, and responsive after-sales support.
Q: How should unused tablets be disposed of?
A: Dispose of unused tablets as per local regulations to prevent environmental contamination. Return to a designated pharmacy or hazardous waste facility if possible.